GitHub repository: opensafely/antibody-and-antiviral-deployment
Primary language: HTML
Description: While vaccines remain the best strategy to prevent COVID-19, mAbs could potentially benefit certain vulnerable populations before or after exposure to SARS-CoV-2, such as the unvaccinated or recently vaccinated high-risk patients.